메뉴 건너뛰기




Volumn 22, Issue 1, 2012, Pages 63-70

Erratum: Cardiovascular considerations of attention deficit hyperactivity disorder medications: A report of the European Network on Hyperactivity Disorders work group, European Attention Deficit Hyperactivity Disorder Guidelines Group on attention deficit hyperactivity disorder drug safety meeting (Cardiology in the Young (2011) DOI: 10.1017/S1047951111000928);Cardiovascular considerations of attention deficit hyperactivity disorder medications: A report of the European Network on Hyperactivity Disorders work group, European Attention Deficit Hyperactivity Disorder Guidelines Group on attention deficit hyperactivity disorder drug safety meeting

Author keywords

Attention deficit hyperactivity disorder; congenital; drug therapy; guidelines; heart disease; stimulant; sudden death

Indexed keywords

AMPHETAMINE; ATOMOXETINE; CLONIDINE; GUANFACINE; METHYLPHENIDATE;

EID: 84857472527     PISSN: 10479511     EISSN: 14671107     Source Type: Journal    
DOI: 10.1017/S1047951111001892     Document Type: Erratum
Times cited : (23)

References (37)
  • 3
    • 0347419387 scopus 로고    scopus 로고
    • Long-Term Use of Stimulants in Children with Attention Deficit Hyperactivity Disorder: Safety, Efficacy, and Long-Term Outcome
    • DOI 10.2165/00148581-200305120-00002
    • Hechtman L, Greenfield B. Long-term use of stimulants in children with attention deficit hyperactivity disorder: safety, efficacy, and long-term outcome. Paediatr Drugs 2003; 5: 787-794. (Pubitemid 38030604)
    • (2003) Pediatric Drugs , vol.5 , Issue.12 , pp. 787-794
    • Hechtman, L.1    Greenfield, B.2
  • 4
    • 3042622074 scopus 로고    scopus 로고
    • Clinical practice guideline: Treatment of the school-aged child with attentiondeficit/ hyperactivity disorder
    • American Academy of Pediatrics SoA-DHD
    • American Academy of Pediatrics SoA-DHD. Clinical practice guideline: treatment of the school-aged child with attentiondeficit/ hyperactivity disorder. Pediatrics 2001; 108: 1033-1044.
    • (2001) Pediatrics , vol.108 , pp. 1033-1044
  • 5
    • 43249096555 scopus 로고    scopus 로고
    • Cardiovascular monitoring of children and adolescents with heart disease receiving stimulant drugs: A scientific statement from the American Heart Association Council on cardiovascular disease in the Young Congenital Cardiac Defects Committee and the Council On Cardiovascular Nursing
    • DOI 10.1161/CIRCULATIONAHA.107.189473, PII 0000301720080506000016
    • Vetter VL, Elia J, Erickson C, et al. Cardiovascular monitoring of children and adolescents with heart disease receiving stimulant drugs: a scientific statement from the American Heart Association Council on Cardiovascular Disease in the Young Congenital Cardiac Defects Committee and the Council on Cardiovascular Nursing. Circulation 2008; 117: 2407-2423. (Pubitemid 351653546)
    • (2008) Circulation , vol.117 , Issue.18 , pp. 2407-2423
    • Vetter, V.L.1    Elia, J.2    Erickson, C.3    Berger, S.4    Blum, N.5    Uzark, K.6    Webb, C.L.7
  • 6
    • 51249120774 scopus 로고    scopus 로고
    • American Academy of Pediatrics/American Heart Association clarification of statement on cardiovascular evaluation and monitoring of children and adolescents with heart disease receiving medications for ADHD: May 16, 2008
    • American Academy of Pediatrics/American Heart Association clarification of statement on cardiovascular evaluation and monitoring of children and adolescents with heart disease receiving medications for ADHD: May 16, 2008. J Dev Behav Pediatr 2008; 29: 335.
    • (2008) J Dev Behav Pediatr , vol.29 , pp. 335
  • 7
    • 84857468770 scopus 로고    scopus 로고
    • Disorders ENoH. EUNETHYDIS ADHD Drug Safety Meeting. Paper presented at, 10-13 March, Zurich
    • Disorders ENoH. EUNETHYDIS ADHD Drug Safety Meeting. Paper presented at EUNETHYDIS ADHD Drug Safety Meeting, 10-13 March, 2009, Zurich.
    • (2009) EUNETHYDIS ADHD Drug Safety Meeting
  • 8
    • 4344603965 scopus 로고    scopus 로고
    • Sudden cardiac death in children and adolescents: Introduction and overview
    • DOI 10.1016/j.pcl.2004.04.008, PII S0031395504000574
    • Berger S, Kugler JD, Thomas JA, Friedberg DZ. Sudden cardiac death in children and adolescents: introduction and overview. Pediatr Clin North Am 2004; 51: 1201-1209. (Pubitemid 39149778)
    • (2004) Pediatric Clinics of North America , vol.51 , Issue.5 , pp. 1201-1209
    • Berger, S.1    Kugler, J.D.2    Thomas, J.A.3    Friedberg, D.Z.4
  • 9
    • 0032491031 scopus 로고    scopus 로고
    • Screening for hypertrophic cardiomyopathy in young athletes
    • DOI 10.1056/NEJM199808063390602
    • Corrado D, Basso C, Schiavon M, Thiene G. Screening for hypertrophic cardiomyopathy in young athletes. N Engl J Med 1998; 339: 364-369. (Pubitemid 28363798)
    • (1998) New England Journal of Medicine , vol.339 , Issue.6 , pp. 364-369
    • Corrado, D.1    Basso, C.2    Schiavon, M.3    Thiene, G.4
  • 10
    • 0021934627 scopus 로고
    • Sudden and unexpected natural death in childhood and adolescence
    • DOI 10.1001/jama.254.10.1321
    • Neuspiel DR, Kuller LH. Sudden and unexpected natural death in childhood and adolescence. J Am Med Assoc 1985; 254: 1321-1325. (Pubitemid 15236604)
    • (1985) Journal of the American Medical Association , vol.254 , Issue.10 , pp. 1321-1325
    • Neuspiel, D.R.1    Kuller, L.H.2
  • 11
    • 33646855404 scopus 로고    scopus 로고
    • ADHD drugs and cardiovascular risk
    • author reply 2296-2298
    • Rappley MD, Moore JW, Dokken D. ADHD drugs and cardiovascular risk. N Engl J Med 2006; 354: 2296-2298; author reply 2296-2298.
    • (2006) N Engl J Med , vol.354 , pp. 2296-2298
    • Rappley, M.D.1    Moore, J.W.2    Dokken, D.3
  • 12
    • 0034024150 scopus 로고    scopus 로고
    • Sudden death in children and adolescents
    • Wren C. Sudden death in children and adolescents. Heart 2000; 83: 410-413. (Pubitemid 30316754)
    • (2000) Heart , vol.83 , Issue.4 , pp. 410-413
    • Wren, C.1    O'Sullivan, J.J.2    Wright, C.3
  • 13
    • 0032127172 scopus 로고    scopus 로고
    • A population-based prospective evaluation of risk of sudden cardiac death after operation for common congenital heart defects
    • DOI 10.1016/S0735-1097(98)00187-9, PII S0735109798001879
    • Silka MJ, Hardy BG, Menashe VD, Morris CD. A populationbased prospective evaluation of risk of sudden cardiac death after operation for common congenital heart defects. J Am Coll Cardiol 1998; 32: 245-251. (Pubitemid 28351069)
    • (1998) Journal of the American College of Cardiology , vol.32 , Issue.1 , pp. 245-251
    • Silka, M.J.1    Hardy, B.G.2    Menashe, V.D.3    Morris, C.D.4
  • 14
    • 34547200411 scopus 로고    scopus 로고
    • Epidemiology of attention-deficit/hyperactivity disorder in the community
    • Sayal K. Epidemiology of attention-deficit/hyperactivity disorder in the community. Br J Hosp Med (Lond) 2007; 68: 352-355. (Pubitemid 47121456)
    • (2007) British Journal of Hospital Medicine , vol.68 , Issue.7 , pp. 352-355
    • Sayal, K.1
  • 15
    • 32644463729 scopus 로고    scopus 로고
    • Long-term neurodevelopmental outcome and exercise capacity after corrective surgery for tetralogy of Fallot or ventricular septal defect in infancy
    • DOI 10.1016/j.athoracsur.2005.09.010, PII S0003497505016073
    • Hovels-Gurich HH, Konrad K, Skorzenski D, et al. Long-term neurodevelopmental outcome and exercise capacity after corrective surgery for tetralogy of Fallot or ventricular septal defect in infancy. Ann Thorac Surg 2006; 81: 958-966. (Pubitemid 43247667)
    • (2006) Annals of Thoracic Surgery , vol.81 , Issue.3 , pp. 958-966
    • Hovels-Gurich, H.H.1    Konrad, K.2    Skorzenski, D.3    Nacken, C.4    Minkenberg, R.5    Messmer, B.J.6    Seghaye, M.-C.7
  • 16
    • 42949177616 scopus 로고    scopus 로고
    • Inattention, hyperactivity, and school performance in a population of school-age children with complex congenital heart disease
    • Shillingford AJ, Glanzman MM, Ittenbach RF, Clancy RR, Gaynor JW, Wernovsky G. Inattention, hyperactivity, and school performance in a population of school-age children with complex congenital heart disease. Pediatrics 2008; 121: e759-e767.
    • (2008) Pediatrics , vol.121
    • Shillingford, A.J.1    Glanzman, M.M.2    Ittenbach, R.F.3    Clancy, R.R.4    Gaynor, J.W.5    Wernovsky, G.6
  • 17
    • 36849078855 scopus 로고    scopus 로고
    • Cardiac safety of central nervous system stimulants in children and adolescents with attention-deficit/hyperactivity disorder
    • DOI 10.1542/peds.2007-0675
    • Winterstein AG, Gerhard T, Shuster J, Johnson M, Zito JM, Saidi A. Cardiac safety of central nervous system stimulants in children and adolescents with attention-deficit/hyperactivity disorder. Pediatrics 2007; 120: e1494-e1501. (Pubitemid 350223669)
    • (2007) Pediatrics , vol.120 , Issue.6
    • Winterstein, A.G.1    Gerhard, T.2    Shuster, J.3    Johnson, M.4    Zito, J.M.5    Saidi, A.6
  • 18
    • 69949090591 scopus 로고    scopus 로고
    • Sudden death and use of stimulant medications in youths
    • Gould MS,Walsh BT, Munfakh JL, et al. Sudden death and use of stimulant medications in youths. Am J Psychiatry 2009; 166: 992-1001.
    • (2009) Am J Psychiatry , vol.166 , pp. 992-1001
    • Gould, M.S.1    Walsh, B.T.2    Munfakh, J.L.3
  • 19
    • 68849086665 scopus 로고    scopus 로고
    • Stimulant use linked to sudden death in children without heart problems
    • Kuehn BM. Stimulant use linked to sudden death in children without heart problems. J Am Med Assoc 2009; 302: 613-614.
    • (2009) J Am Med Assoc , vol.302 , pp. 613-614
    • Kuehn, B.M.1
  • 20
    • 79957880103 scopus 로고    scopus 로고
    • Cardiovascular events and death in children exposed and unexposed to ADHD agents
    • Schelleman H, Bilker WB, Strom BL, et al. Cardiovascular events and death in children exposed and unexposed to ADHD agents. Pediatrics 2011; 127: 1102-1110.
    • (2011) Pediatrics , vol.127 , pp. 1102-1110
    • Schelleman, H.1    Bilker, W.B.2    Strom, B.L.3
  • 22
    • 0028606736 scopus 로고
    • Drug-induced torsade de pointes. Incidence, management and prevention
    • Faber TS, Zehender M, Just H. Drug-induced torsade de pointes. Incidence, management and prevention. Drug Saf 1994; 11: 463-476.
    • (1994) Drug Saf , vol.11 , pp. 463-476
    • Faber, T.S.1    Zehender, M.2    Just, H.3
  • 24
    • 34250331569 scopus 로고    scopus 로고
    • QTc-prolonging drugs and the risk of sudden death
    • Reingardiene D, Vilcinskaite J. QTc-prolonging drugs and the risk of sudden death. Medicina (Kaunas) 2007; 43: 347-353.
    • (2007) Medicina (Kaunas) , vol.43 , pp. 347-353
    • Reingardiene, D.1    Vilcinskaite, J.2
  • 26
    • 0036929584 scopus 로고    scopus 로고
    • Safety profile of atomoxetine in the treatment of children and adolescents with ADHD
    • Wernicke JF, Kratochvil CJ. Safety profile of atomoxetine in the treatment of children and adolescents with ADHD. J Clin Psychiatry 2002; 63 (Suppl 12): 50-55. (Pubitemid 36025588)
    • (2002) Journal of Clinical Psychiatry , vol.63 , Issue.SUPPL. 12 , pp. 50-55
    • Wernicke, J.F.1    Kratochvil, C.J.2
  • 27
    • 0034096534 scopus 로고    scopus 로고
    • Cost effectiveness analysis of screening of high school athletes for risk of sudden cardiac death
    • Fuller CM. Cost effectiveness analysis of screening of high school athletes for risk of sudden cardiac death. Med Sci Sports Exerc 2000; 32: 887-890. (Pubitemid 30230667)
    • (2000) Medicine and Science in Sports and Exercise , vol.32 , Issue.5 , pp. 887-890
    • Fuller, C.M.1
  • 28
    • 77949808400 scopus 로고    scopus 로고
    • Modeled economic evaluation of alternative strategies to reduce sudden cardiac death among children treated for attention deficit/ hyperactivity disorder
    • Denchev P, Kaltman JR, Schoenbaum M, Vitiello B. Modeled economic evaluation of alternative strategies to reduce sudden cardiac death among children treated for attention deficit/ hyperactivity disorder. Circulation 2010; 121: 1329-1337.
    • (2010) Circulation , vol.121 , pp. 1329-1337
    • Denchev, P.1    Kaltman, J.R.2    Schoenbaum, M.3    Vitiello, B.4
  • 30
    • 33749367428 scopus 로고    scopus 로고
    • Trends in sudden cardiovascular death in young competitive athletes after implementation of a preparticipation screening program
    • DOI 10.1001/jama.296.13.1593
    • Corrado D, Basso C, Pavei A, Michieli P, Schiavon M, Thiene G. Trends in sudden cardiovascular death in young competitive athletes after implementation of a preparticipation screening program. J Am Med Assoc 2006; 296: 1593-1601. (Pubitemid 44515020)
    • (2006) Journal of the American Medical Association , vol.296 , Issue.13 , pp. 1593-1601
    • Corrado, D.1    Basso, C.2    Pavei, A.3    Michieli, P.4    Schiavon, M.5    Thiene, G.6
  • 31
    • 0029979686 scopus 로고    scopus 로고
    • Cost-effectiveness analysis in a setting of budget constraints: Is it equitable?
    • DOI 10.1056/NEJM199605023341807
    • Ubel PA, DeKay ML, Baron J, Asch DA. Cost-effectiveness analysis in a setting of budget constraints - is it equitable? N Engl J Med 1996; 334: 1174-1177. (Pubitemid 26137978)
    • (1996) New England Journal of Medicine , vol.334 , Issue.18 , pp. 1174-1177
    • Ubel, P.A.1    Dekay, M.L.2    Baron, J.3    Asch, D.A.4
  • 33
    • 29944434794 scopus 로고    scopus 로고
    • Effect of stimulants on 24-h ambulatory blood pressure in children with ADHD: A double-blind, randomized, cross-over trial
    • DOI 10.1007/s00467-005-2051-1
    • Samuels JA, Franco K, Wan F, Sorof JM. Effect of stimulants on 24-h ambulatory blood pressure in children with ADHD: a double-blind, randomized, cross-over trial. Pediatr Nephrol 2006; 21: 92-95. (Pubitemid 43040200)
    • (2006) Pediatric Nephrology , vol.21 , Issue.1 , pp. 92-95
    • Samuels, J.A.1    Franco, K.2    Wan, F.3    Sorof, J.M.4
  • 35
    • 0033596691 scopus 로고    scopus 로고
    • Cardiovascular monitoring of children and adolescents receiving psychotropic drugs: A statement for healthcare professionals from the committee on congenital cardiac defects, council on cardiovascular disease in the young, American Heart Association
    • Gutgesell H, Atkins D, Barst R, et al. Cardiovascular monitoring of children and adolescents receiving psychotropic drugs: a statement for healthcare professionals from the Committee on Congenital Cardiac Defects, Council on Cardiovascular Disease in the Young, American Heart Association. Circulation 1999; 99: 979-982. (Pubitemid 29094318)
    • (1999) Circulation , vol.99 , Issue.7 , pp. 979-982
    • Gutgesell, H.1    Atkins, D.2    Barst, R.3    Buck, M.4    Franklin, W.5    Humes, R.6    Ringel, R.7    Shaddy, R.8    Taubert, K.A.9
  • 36
    • 70449120823 scopus 로고    scopus 로고
    • Safety and effectiveness of coadministration of guanfacine extended release and psychostimulants in children and adolescents with attention-deficit/hyperactivity disorder
    • Spencer TJ, Greenbaum M, Ginsberg LD, Murphy WR. Safety and effectiveness of coadministration of guanfacine extended release and psychostimulants in children and adolescents with attention-deficit/hyperactivity disorder. J Child Adolesc Psychopharmacol 2009; 19: 501-510.
    • (2009) J Child Adolesc Psychopharmacol , vol.19 , pp. 501-510
    • Spencer, T.J.1    Greenbaum, M.2    Ginsberg, L.D.3    Murphy, W.R.4
  • 37
    • 70350454952 scopus 로고    scopus 로고
    • Management of high blood pressure in children and adolescents: Recommendations of the European Society of Hypertension
    • Lurbe E, Cifkova R, Cruickshank JK, et al. Management of high blood pressure in children and adolescents: recommendations of the European Society of Hypertension. J Hypertens 2009; 27: 1719-1742.
    • (2009) J Hypertens , vol.27 , pp. 1719-1742
    • Lurbe, E.1    Cifkova, R.2    Cruickshank, J.K.3


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.